Diabetes research information and news.
Discover the game-changer! Implantable glucagon device revolutionize diabetes care for low blood sugar relief. Glucagon Implantable Device Overview MIT’s Ingenious Device Design Brilliant minds at MIT have whipped up a life-saving gizmo for those grappling with Type 1 diabetes. This nifty piece of tech serves as a lifeline when blood sugar levels plummet. Imagine having…
New cutting-edge pancreas preservation methods with the innovative Pancreas Pack. Enhancing organ viability for diabetes patients. Advancements in Organ Preservation Things are getting interesting in the world of organ preservation, especially for those counting on a new pancreas to help manage diabetes. Some neat new tricks and gadgets are changing the game of pancreas preservation…
Sana Biotechnology’s new type of stem cell transplant islet cells shows promise for a potential treatment for type 1 diabetes. The therapy, UP421 stem cell transplant enrolled patients to avoid immune rejection and produce insulin. As Per-Ola Carlsson, M.D., study principal pnvestigator, senior physician and professor at the Clinic for Endocrinology and Diabetology at Uppsala…
Many folks find it tough to grasp how their body regulates blood sugar. Alpha and beta cells, which are within clusters called “Islets of Langerhans” and are located in the pancreas, are key to this process. This piece will break down what these important endocrine cells do and how they affect your well-being, especially in…
Diabetes affects millions of people worldwide with blood conditions that change the way they live their day-to-day lives. So, scientists and doctors alike are constantly looking for ways to improve treatment options and enhance patient outcomes. Clinical trials are one of the main ways to gather information from those who actually suffer from diabetes. As well…
Previously Published on Genprex.com — Genprex, Inc. (“Genprex” or the “Company”) , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that data highlighting the potential of Genprex’s gene therapy for Type 1 diabetes is being presented by its research collaborators at the University of Pittsburgh (Pitt) at the 16th International…
Previously Published on Fiercebiotech.com – Just a week after Vertex’s stem cell therapy to treat type 1 diabetes was released from an FDA clinical hold, the company is clearing out potential competition by buying ViaCyte for $320 million. The all-cash deal announced Monday throws a net around ViaCyte’s stem cell-based treatment for type 1 diabetes, which has…
Previously Published on medwireNews – The iLet bionic pancreas closed-loop insulin delivery system provides good glucose control without the need for the user to count carbohydrates, show findings from the pivotal trial. Bionic pancreas removes math from diabetes. Instead of counting carbohydrates, users of the Beta Bionics iLet insulin-only bionic pancreas just make meal announcements with the modifier of…
Previously Published on denver.cbslocal.com – Some of the most advanced research in diabetes is being done right here in Colorado. The Barbara Davis Center is world renowned for the care and research of Type 1 diabetes. On the first floor at the center, doctors provide care to patients. In the labs on the upper floors, researchers…